ROMO1 and myeloid sarcoma: While MS samples did not show significantly higher overall ROMO1 expression compared to HC, we observed significant decreases in T cells CD4+ (P < 0.01), Monocytes CD14 + HLA-DR+ (P < 0.001), and NK cells (P < 0.001).